The transmission of bloodborne viruses to healthcare workers can have serious consequences not only for clinical practice but also, because of the requirements of health and safety legislation, for their employers.
1 In spite of guidance and education, 2 however, many healthcare workers continue to be exposed to bloodborne viruses from percutaneous, mucocutaneous, or other injuries. An enhanced system of surveillance of occupational exposure to bloodborne viruses was introduced in mid-1997, developing the passive system that was set up after the first reported case (in 1984) in the United Kingdom of HIV seroconversion associated with needlestick injury.
3

Methods and results
Since July 1997 occupational health departments have been requested to complete a brief form outlining the circumstances of any work related exposure to potentially infectious material from patients who are known to be positive for HIV antibodies or hepatitis C antibodies, or for hepatitis B surface antigens. For exposures to HIV or hepatitis C virus, the follow up at six weeks includes more information about the incident, baseline testing of both the healthcare worker and the source patient, and, for exposure to HIV, details of post-exposure prophylaxis.
A total of 813 initial reports were received of exposure of healthcare workers to bloodborne viruses between July 1997 and June 2000: 725 reports of exposure to only one of the bloodborne viruses, 83 to two, and five to all three. After records with missing information were excluded, the most commonly reported exposed groups were nurses and midwives (45% (308/678) of the health professionals exposed) and doctors (38% (255/678)) (table), and percutaneous injuries were the most commonly reported type of exposure (70%).
Six week follow up reports were received for 507 of the incidents. These recorded that 64% (323) involved exposure during a procedure, 20% (100) after the procedure but before disposal of equipment, and 13% (64) during or after disposal; in 4% (20) the nature of the incident was not reported. Post-exposure prophylaxis was recorded for 138 of the healthcare workers exposed to HIV: 43 were known to have fully completed four weeks of treatment, 19 workers completed the course for some drugs, and 38 completed none. In 38 workers post-exposure prophylaxis was started but the length of treatment was not recorded. Side effects caused by post-exposure prophylaxis were recorded in 77 healthcare workers.
One transmission occurred among 293 exposures to HIV despite post-exposure prophylaxis, and none in 462 exposures to hepatitis C virus. However, reports of follow up at six months have not been received for all of these.
Comment
Thanks to the cooperation of occupational health departments, the enhanced surveillance system has been successful both in increasing the number of incidents reported and in expanding its coverage to hepatitis B and C. The case of HIV transmission described above brings the total number of occupationally acquired HIV infections reported in the United Kingdom to five. A further 11 reported cases among healthcare workers in the United Kingdom are associated with work overseas in areas of high prevalence of HIV. The low rate of completion of the recommended course of post-exposure prophylaxis indicates the importance of regular support during the four weeks of the course. In March 2000 a six month follow up form was introduced that asks retrospectively for evidence of the healthcare worker's post-exposure infection status. Although transmissions of HIV among healthcare workers after recorded exposures are unlikely to go unrecognised, assessing transmission rates of hepatitis C virus requires routine testing. No seroconversions have occurred among the 142 healthcare workers for whom post-exposure testing for hepatitis C virus has been formally reported (95% confidence interval 0% to 3.35%), indicating a lower risk of transmission of this virus than has been reported elsewhere.
4 5 However, only 102 exposures were due to percutaneous needlestick injury, and only 65 of these were from a hollow bore needle. Such exposures probably do carry a considerable risk of transmission of hepatitis C virus. One report of such a transmission was received, but the exposure occurred in 1996, before the enhanced surveillance period.
Although exposures to hepatitis B virus among vaccinated individuals may not be well reported, the 151 occupational exposures recorded here indicate the continuing importance of maintaining rigorous programmes of vaccination of healthcare workers. The management of prisoners infected with HIV-1 is challenging: a high proportion are injecting drug users, there are issues regarding confidentiality, and administering complex antiretroviral regimens may be difficult in prison. We reviewed our experience of providing specialist HIV care to prisoners between October 1994 and July 1999.
Participants, methods, and results
In October 1994, King's College Hospital was contracted to provide care to male prisoners with HIV-1 and sexually transmitted diseases at Wandsworth and Brixton prisons in south London. Prisoners access the service through self referral or referral by wing officers and prison healthcare workers. Between October 1994 and July 1999 six prisoners were newly diagnosed as positive for antibodies to HIV-1 and 121 said that they had previously tested positive for antibodies to HIV-1. Of those 121, 75 were confirmed as positive for antibodies to HIV-1 and 25 tested negative for antibodies to HIV-1. Fourteen of the remaining 21 who declined to be tested gave information to support their claim, including their HIV treatment centre. In all cases this information proved to be false. Documented reasons for this subterfuge included the desire for a letter pleading mitigating circumstances in court or a request for food supplements, sedatives, or opioids.
Of 81 patients confirmed as positive for antibodies to HIV-1, 77% (62/81) were white and 16% (13/81) were black-African. The median age at first assessment in prison was 33 (range 23-65) years and the main HIV risk factor recorded was injecting drug use (59%; 48/81). The median CD4 count was 210 × 10 6 /l (range 4-740 × 10 6 /l) and a fifth were severely immunosuppressed (CD4 < 50 × 10 6 /l). Twenty one (26%) had AIDS, 41 (51%) were coinfected with hepatitis C, and five (6%) also had chronic hepatitis B.
Inmates were reviewed regularly to assess clinical status and adherence to antiretroviral treatment. As expected, they were significantly more likely to keep BMJ 2001; 322:398-9 
